Taken together, these results suggest that the inhibition of EPH signaling is able to affect CRC-transformed phenotypes by inducing either quiescence or senescence, but not cell death, in a cell type-dependent manner. The gene discussed is EPHA1; the disease is colorectal carcinoma.